BioSpace News Archive

Trianni today announced that Juno has entered into a license agreement for The Trianni Mouse, a best-in-class monoclonal antibody discovery platform.

Trovagene today announced positive data from preclinical research demonstrating synergy of PCM-075, its oral, highly-selective Polo-like Kinase 1 (PLK1) Inhibitor, in combination with abiraterone (Zytiga - J&J)/

Haemonetics announced the election of Robert E. Abernathy to its Board of Directors.

Respiratory Motion announced today its plans to launch the newest version of its ExSpiron 1Xi Minute Ventilation (MV) Monitor at the ASA in Boston, October 21-25 following recent FDA clearance.

On August 2, 2017, an American surgical team conducted a surgery to replace the sternum and partial ribcage of a 20 year-old woman using a custom 3D-printed composite titanium/porous polyethylene implant. It is the first time this technology has been used in the United States and only the second time in the world that a 3D-printed composite sternum and ribcage has been implanted.

Aytu BioScience today announced that its shares of common stock were approved for listing on The NASDAQ Capital Market.

Biocept announces the launch of its molecular pathology partnership initiative, the aim of which is to incorporate community pathologists into the review of biomarkers found in liquid biopsy for patients diagnosed with cancer.

SCORR Marketing, a global health science marketing and communications firm, and Applied Clinical Trials have released a new study, Collaborative R&D Survey Report.

Blade Therapeutics announced that it has nominated a clinical development candidate for its lead program focused on small molecule inhibitors that selectively target certain intracellular cysteine proteases.

Phytecs, Inc., a biotechnology company exploring potential therapies that target the body’s endocannabinoid system (ECS) to treat disease, today announced the addition of new members to the company’s Scientific Advisory Board.